United States: EPA Finalizes TSCA Reform Framework Rules

On July 20, 2017, EPA published in the Federal Register two final rules intended to begin implementation of the Frank R. Lautenberg Chemical Safety for the 21st Century Act (Lautenberg Act), which significantly reformed the Toxic Substances Control Act (TSCA). The two final rules are the Procedures for Prioritization of Chemicals for Risk Evaluation Under the Toxic Substances Control Act, 82 Federal Register 33753 (Prioritization Rule) and Procedures for Chemical Risk Evaluation under the Amended Toxic Substances Control Act, 82 FR 33726 (Risk Evaluation Rule).  A third TSCA framework rule—the TSCA Inventory Notification (Active/Inactive) Requirements rule (Inventory Rule)—has not yet been published in the Federal Register, although a pre-publication version was released in June 2017 (we previously reported on all three proposed rules here).  Together, these three rules will help the Agency implement the extensive reforms set out in motion by the Lautenberg Act.

The Prioritization Rule and the Risk Evaluation Rule will become effective on September 18, 2017. Upon publication of the Active/Inactive Final Rule in the Federal Register – which EPA has indicated will become effective upon publication – a 180-day clock will be triggered for affected manufacturers, and affected processors must comply within 420 days of publication.

Finally, EPA published the notice of availability of Guidance to Assist Interested Persons in Developing and Submitting Draft Risk Evaluations, a guidance document intended to assist stakeholders with developing and submitting their draft risk evaluations, and has uploaded draft scoping documents for the first ten chemicals for which EPA is required to perform risk evaluations under the Lautenberg Act to its website (EPA's initiation of the risk evaluation for these ten chemicals was previously discussed here).

Prioritization Rule

Under the Lautenberg Act, EPA is required to establish a risk-based screening process and criteria to designate chemicals as High or Low-Priority Substances. The Prioritization Rule establishes this process.  The rule incorporates the definitions of "High-Priority Substance" and "Low-Priority Substance" directly from the Act, and, as required by the Act, dictates that a substance be designated as a "High Priority substance" if, after an extension of the public comment period, "information remains insufficient to enable the proposed designation of the chemical substance as a Low-Priority Substance."  40 C.F.R. § 702.9(e).

As a reminder, under the Lautenberg Act, the Agency is required to designate at least 20 High Priority and Low Priority substances within 3 years of the Act's passage, with an additional 5 substances in each category within 5 years of enactment.  And, EPA must select a sufficient number of candidates for priority designations from EPA's 2014 Work Plan to ensure that, at any given time, at least 50 percent of risk evaluations being conducted by EPA are drawn from that list.

EPA indicates in the final rule that High- and Low-Priority designations will apply to a chemical substance as a whole, rather than to a specific use of that chemical substance, which is nominally consistent with the proposal. Nevertheless, the Agency does appear to seek additional flexibility to narrow the scope of its review by allowing itself to exclude certain "conditions of use," stating that "this does not mean that in prioritization, EPA will necessarily consider every activity involving the chemical substance to be a 'condition of use.'"  82 FR at 33755.

Other notable departures from the proposal include that (a) EPA has deleted the pre-prioritization provisions, instead indicating that it will develop a separate process for selecting candidates for prioritization, with more information to follow this fall, (b) substitutes will no longer be considered during the prioritization process, and (c) EPA has now shifted the screening review to occur after the initial public comment period, to increase the opportunity for stakeholders to provide input to the screening review.  Finally, the Agency seeks to give the regulated community some comfort that chemical substances that have been newly added to the TSCA Inventory (through completion of the pre-manufacture review process) and those that have been identified as "inactive" on the TSCA Inventory are "less likely to be selected as early High-Priority candidates." Id. at 33756.

As required by the Lautenberg Act, the final rule requires EPA to complete the prioritization process (from initiation to final priority designation) within nine to twelve months after EPA publishes a notice in the Federal Register identifying the chemical substance for prioritization, thereby initiating a 90-day public comment period.

Risk Evaluation Rule

Once chemical substances are designated as High-Priority, the Risk Evaluation Rule establishes the process EPA will follow to "determine whether a chemical substance presents an unreasonable risk of injury to health or the environment, without consideration of costs or other non-risk factors, including an unreasonable risk to a potentially exposed or susceptible subpopulation identified as relevant to the risk evaluation by the Administrator under the conditions of use." 15 U.S.C. § 2605(b)(4)(A).  The final Risk Evaluation Rule departs from the proposal, which had been issued by the previous Administration, in several ways.

In what some stakeholders are asserting is a significant departure from the proposal, EPA indicates in the final rule that it need not include all conditions of use in the scope of its risk evaluation, suggesting that intentional misuses, legacy uses (those not associated with ongoing or prospective manufacturing, processing, or distribution), and substances that appear as impurities or byproducts, among other uses, may not be included within the scope of a risk evaluation on a case-by-case basis. Yet, EPA states in the preamble that the Agency will always plan to "include[] an evaluation of the conditions of use that raise greatest potential for risk." 82 FR at 33728.

In addition, the final rule adds a mechanism for EPA to finalize partial risk evaluations where the Agency has sufficient information to determine whether a chemical presents an unreasonable risk under particular conditions of use. This provision appears responsive to the regulated community by allowing the Agency to preempt state laws restricting a given use sooner than later when the Agency has sufficient information to conclude that a certain use of a given chemical does not present an unreasonable risk of harm.

Finally, the rule includes a definition of "best available science," defining it as "science that is reliable and unbiased. Use of best available science involves the use of supporting studies conducted in accordance with sound and objective science practices, including, when available, peer reviewed science and supporting studies and data collected by accepted methods or best available methods (if the reliability of the method and the nature of the decision justifies use of the data)," and goes on to list additional factors the Agency will consider in evaluating whether the information qualifies as "best available science." 40 C.F.R. § 702.33.  Notably, EPA declined to codify some relevant definitions (including "sufficiency of information" and "unreasonable risk"), but the Agency has stated it will provide further information on applicability of these terms and their meaning in later guidance documents.

As a reminder, under the Lautenberg Act, the risk evaluation process may not last more than three years, though a potential six-month extension may be granted in some circumstances.

TSCA Inventory Notification (Active/Inactive) Requirements

On January 13, 2017, EPA published a Proposed Rule entitled TSCA Inventory Notification (Active-Inactive) Requirements, 82 FR 4255 (Active/Inactive Rule).  A pre-publication version of the final rule was released in June 2017, but as of the date of this post, the Final Rule has not yet been published in the Federal Register.  According to EPA, the Active/Inactive Rule will "enable [it] to fulfill a statutory obligation to designate chemical substances on the TSCA Inventory as active or inactive in U.S. commerce."  While all of the recent rules will impact industry, the Active/Inactive Rule is likely to have the most immediate effect, since publication of the Final Rule in the Federal Register will start the clock on compliance with important 180-day and 420-day reporting deadlines.

Retrospective Notification

According to the pre-publication notice, the final Active/Inactive Rule establishes a retrospective electronic reporting requirement (through submittal of a "Notice of Activity Form A") for chemical substances on the TSCA Inventory that were manufactured (including those chemical substances that were imported) for nonexempt commercial purposes between June 21, 2006 and June 21, 2016. According to EPA, the active/inactive status will help inform the Agency's prioritization of chemical substances for the risk evaluations described above.

Notably, the final Active/Inactive Rule provides three important exemptions for the required electronic notice, based on the theory that the Agency has already received adequate notice that the chemical substance was manufactured during the ten-year period in some other manner:

  1. Chemical substances for which a Chemical Data Report was submitted in either 2012 or 2016. These chemical substances will automatically be designated as "active."
  2. Chemical substances added to the TSCA Inventory during the ten-year period through a Notice of Commencement (NOC) received by EPA during that period. These chemical substances will also be automatically designated as "active."
  3. Chemical substances for which the manufacturer has evidence—in the form of a Central Data Exchange receipt—that EPA already received a Notice of Activity Form A for the substance from another manufacturer.

Manufacturers must make retrospective reports no later than 180 days after the rule is published in the Federal Register, while processors have 420 days following Federal Register publication (note that the 420-day notification period is longer than the 360-day period in the Proposed Rule).

In a departure from the proposal, EPA is no longer requiring that companies report the commercial activity type and the date range of manufacture as part of the required submittal.

In addition to explaining the active/inactive designation, the Final Rule also sets forth the logistics for submitting the notifications, potential exceptions from the notification requirements, and procedures for handling confidential business information (CBI). Most importantly, as required by the Lautenberg Act, the final rule emphasizes that companies must submit substantiation for CBI for substances listed on the confidential portion of the TSCA Inventory as part the retrospective submittal, otherwise the substance will be moved from the confidential to the public portion of the Inventory.

Prospective Notification

The final Active/Inactive Rule also sets forth procedures for companies to submit an electronic notice to EPA to notify the Agency of intent to manufacture a previously designated inactive chemical. The reporting requirement will begin on the effective date of EPA's final active/inactive substance designations, which will occur once EPA publishes a new version of the TSCA inventory with the relevant designations.  After that date, processors and/or manufacturers must submit prospective notifications no more than ninety days prior to reintroducing the substance into commerce (as opposed to the 30-day timeframe under the proposal).  Processing or manufacturing a chemical substance that is labeled "inactive" before its designation has been prospectively changed to "active" is considered a TSCA violation.  Notably, even if the intended manufacturing never occurs, the final rule does not require a submitter to revise or rescind its notice.

For questions related to these TSCA framework rules or the Lautenberg Act, please contact Angela Levin or Laura Boorman.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
Arnold & Porter
Smith Gambrell & Russell LLP
Arnold & Porter
Arnold & Porter
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Arnold & Porter
Smith Gambrell & Russell LLP
Arnold & Porter
Arnold & Porter
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions